Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Dow Inc
DOW
|
+$123M |
| 2 |
Newmont
NEM
|
+$77.1M |
| 3 |
Corteva
CTVA
|
+$72.5M |
| 4 |
Amcor
AMCR
|
+$60.2M |
| 5 |
Alibaba
BABA
|
+$47.4M |
Top Sells
| 1 |
DuPont de Nemours
DD
|
+$101M |
| 2 |
Apple
AAPL
|
+$94.5M |
| 3 |
GG
Goldcorp Inc
GG
|
+$78.3M |
| 4 |
Microsoft
MSFT
|
+$77.6M |
| 5 |
Pfizer
PFE
|
+$53.9M |
Sector Composition
| 1 | Technology | 19.94% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 11.95% |
| 4 | Communication Services | 10.13% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Liberty Latin America Class A
LILA
$1.51B
| $1.4M | ﹤0.01% |
86,153
+1,803
| +2% | +$29.3K |
|
1927
Extreme Networks
EXTR
$2.96B
| $1.4M | ﹤0.01% |
215,700
| – | – |
|
1928
Virtus Investment Partners
VRTS
$1.31B
| $1.4M | ﹤0.01% |
13,000
| – | – |
|
|
AKS
1929
DELISTED
AK Steel Holding Corp.
AKS
| $1.4M | ﹤0.01% |
588,500
+13,500
| +2% | +$32K |
|
1930
Travere Therapeutics
TVTX
$2.43B
| $1.39M | ﹤0.01% |
69,400
+1,700
| +3% | +$34.1K |
|
|
CARO
1931
DELISTED
Carolina Financial Corp.
CARO
| $1.39M | ﹤0.01% |
39,600
+500
| +1% | +$17.6K |
|
|
MAGN
1932
Magnera Corporation
MAGN
$404M
| $1.38M | ﹤0.01% |
6,300
+162
| +3% | +$35.5K |
|
|
DRNA
1933
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.38M | ﹤0.01% |
87,600
+7,600
| +10% | +$120K |
|
1934
Marten Transport
MRTN
$949M
| $1.38M | ﹤0.01% |
113,975
+2,250
| +2% | +$27.2K |
|
1935
Triumph Financial, Inc.
TFIN
$1.42B
| $1.37M | ﹤0.01% |
47,200
+4,100
| +10% | +$119K |
|
1936
E.W. Scripps
SSP
$246M
| $1.37M | ﹤0.01% |
89,516
+2,800
| +3% | +$42.8K |
|
1937
AngioDynamics
ANGO
$445M
| $1.36M | ﹤0.01% |
69,100
+1,400
| +2% | +$27.6K |
|
|
CNR
1938
Core Natural Resources, Inc.
CNR
$3.74B
| $1.36M | ﹤0.01% |
51,132
+10,600
| +26% | +$282K |
|
1939
Omeros
OMER
$291M
| $1.36M | ﹤0.01% |
86,700
+1,900
| +2% | +$29.8K |
|
1940
Amphastar Pharmaceuticals
AMPH
$1.32B
| $1.36M | ﹤0.01% |
64,400
+1,400
| +2% | +$29.5K |
|
1941
Adtran
ADTN
$828M
| $1.36M | ﹤0.01% |
88,900
+2,100
| +2% | +$32K |
|
1942
ANI Pharmaceuticals
ANIP
$2.11B
| $1.36M | ﹤0.01% |
16,500
+300
| +2% | +$24.7K |
|
|
SP
1943
DELISTED
SP Plus Corporation
SP
| $1.35M | ﹤0.01% |
42,400
+900
| +2% | +$28.7K |
|
|
GMS
1944
DELISTED
GMS Inc
GMS
| $1.35M | ﹤0.01% |
61,300
+1,300
| +2% | +$28.6K |
|
1945
Modine Manufacturing
MOD
$7.95B
| $1.35M | ﹤0.01% |
94,200
+1,800
| +2% | +$25.8K |
|
|
UBNK
1946
DELISTED
United Financial Bancorp, Inc.
UBNK
| $1.35M | ﹤0.01% |
94,965
+2,000
| +2% | +$28.4K |
|
1947
Preferred Bank
PFBC
$1.17B
| $1.35M | ﹤0.01% |
28,489
+2,000
| +8% | +$94.5K |
|
1948
ArcBest
ARCB
$1.61B
| $1.34M | ﹤0.01% |
47,600
+700
| +1% | +$19.7K |
|
|
AUD
1949
DELISTED
Audacy, Inc.
AUD
| $1.34M | ﹤0.01% |
230,644
+3,500
| +2% | +$20.3K |
|
|
CMO
1950
DELISTED
Capstead Mortgage Corp.
CMO
| $1.34M | ﹤0.01% |
160,200
-3,600
| -2% | -$30.1K |
|